The Market report provides critical insights on the market size, share, trend, forecasts, and opportunity analysis.
The newly launched report by Stratview Research, titled ‘Tissue Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2021-2026’ has been bifurcated by Product Type (Consumables [Antibodies, Kits, Reagents, and Probes] and Instruments [Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments]), by Technology Type (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining), by Disease Type (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Diseases), by End-User Type (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
According to the report Tissue Diagnostics Market is likely to witness a steady CAGR of 6.9%, during the forecast period owing to the high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness. In addition, technological advancements in the field of tissue diagnostics and aging population are further expected to bolster the growth of the market during the forecast period.
How does this report help?
Reports published by Stratview Research helps the users in several ways. The user can –
Market Segmentation Analysis -
Based on the product type, the market is segmented as consumables and instruments. The consumables segment is expected to register a higher growth during the forecast period. The growth of the segment is attributed to the cost-effectiveness and ease of use of consumables. Furthermore, the growing number of reagent rental agreements is also one of the major factors driving the growth of the consumables market.
Based on the technology type, the market is segmented as immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. The immunohistochemistry segment is expected to lead the market over the forecast period. The increasing number of chronic diseases can be attributed to the segment's growth, where this technology is mostly used in tissue diagnostics.
Based on the disease type, the market is segmented as breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other diseases. Breast cancer is expected to be the dominant disease type during the forecast period due to its increasing number of cases. In addition, advancements in the field of tissue diagnostics and increase in investment for the development of products for breast cancer diagnosis are expected to contribute to the growth of the segment during the forecast period.
The following are the key players in the market-
Stratview Research's reports are the result of a thorough analysis that combines thorough secondary, and primary interviews with industry leaders, and confirmation using unique internal database and statistical methods. More than 1,000 verified secondary sources, such as annual reports from companies, press releases, fact books, journals, white papers, and blogs are reviewed and analysed.
About Stratview Research -
Stratview Research is one of the leading providers of custom and syndicated market research reports. We also offer services like Sourcing, Market Entry Strategy, Target Screening, Voice of Market Study, and much more. In case of any requirement related to market assessment, competitive benchmarking, and others, please send your inquiry to the team.
Email at - [email protected]
Connect with the analysts at - +1-313-307-4176.
FESTIVALS IN INDIA
BAR & CAFES
TRAVEL & EVENTS
NEWS & POLITICS
CARS & VEHICLES
ECONOMICS & TRADE
PETS & ANIMALS
MOVIES & ANIMATION
HOME & GARDEN
GIFTS & OCCASIONS
BEAUTY PRODUCTS & SERVICES
BABY & CHILDREN'S PRODUCTS